Buyer for gynecology and urology pharma product distributor

Company to buy

• Size: Medium 
• Sales: 10 – 50 million EUR
• Location: Europe
• Reason for acquisition: The management wants to expand their business
• #CFIE PHB191

Overview of buyer for gynecology and urology pharma product distributor

The company operates in the pharmaceutical sector and specializes in sexual health medicine. Furthermore, the company seeks a medium-sized target with capabilities in gynecology, urology, pharmaceutical distribution, generic drugs, and drug distribution. Specifically, the target revenue range is between 10 and 50 million euros. The ideal target should operate in Central Europe.

Profile (strategy) of buyer for gynecology and urology pharma product distributor

The company began as a pharma company specializing in women’s sexual health and retains this as a core strength. Over time, the company’s portfolio evolved and now it encompasses gynecological, urological, sexual health, and medical device products. For instance, contraceptive drugs and STD drugs, as well as erectile disorders and urinary incontinence, are some of the key additions to its portfolio.
in addition, the buyer has extensive experience in male and female urological drugs and treatments and has successfully ventured into treatments for erectile dysfunction. Its urological portfolio includes drugs and treatments for issues relating to the bladder, ureter, and urethra, as well as prostate, penis, and testicle-related health issues. Most importantly, the company has pursued a strategy of entering the STD treatment area as well, in a strong partnership with health professionals and public institutions in providing drugs and raising awareness.

Activities and products of a suitable target

The target company sought should operate in Central Europe ideally, in the revenue range of 10 to 50 million euros annually. Additionally, the target company should have strong capabilities in gynecology, urology, pharmaceutical distribution, generic drugs, and drug distribution. Further, the buyer company is considering an ideal target employee range from 3 to 20 personnel. Relating to EBITDA, the ideal range is from 2 to 25 million euros. Above all, companies that have more than three years of experience are preferred.

Highlights

• Strong experience in sexual health, gynecology, urology, pharmaceutical distribution, generic drugs, and drug distribution
• Long history in the niche of women’s health and sexual health drugs and treatments
• Successful business ventures into related areas such as erectile dysfunction and STDs
• The buyer is interested in medium-sized Central European companies with capabilities in gynecology, urology, and drug distribution
• Synergies in product distribution are a key strength of potential targets

More information on this buyer for gynecology and urology pharma product distributor

Please get in touch if you are interested in learning more about this buyer for gynecology and urology pharma product distributor. For more pharma distributors companies for sale please visit the section pharma distributors companies for sale. For other pharma distributors buyers, please visit the section pharma distributors companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.